Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa

J Am Acad Dermatol. 2016 Nov;75(5):1059-1062. doi: 10.1016/j.jaad.2016.06.001.

Authors

Dennis Wong¹, Scott Walsh², Raed Alhusayen²

Affiliations

¹ Department of Medicine, University of Toronto, Toronto, Ontario. Electronic address: dennisd.wong@mail.utoronto.ca.
² Department of Medicine, University of Toronto, Toronto, Ontario; Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario.

PMID: 27745633
DOI: 10.1016/j.jaad.2016.06.001

No abstract available

MeSH terms

Adalimumab / adverse effects
Adalimumab / therapeutic use
Adult
Aged
Anti-Bacterial Agents / therapeutic use
Drug Therapy, Combination
Female
Hidradenitis Suppurativa / drug therapy*
Humans
Hyperglycemia / chemically induced
Male
Mental Disorders / chemically induced
Middle Aged
Prednisone / administration & dosage
Prednisone / adverse effects
Prednisone / therapeutic use*
Young Adult

Substances

Anti-Bacterial Agents
Adalimumab
Prednisone